Orthofix Medical Inc. provided net sales guidance for the year ended December 31, 2022. For the year, company expects net sales to be $475.0 million to $490.0 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.68 USD | -0.16% | +2.35% | -6.00% |
06-18 | Orthofix Medical Inc. Appoints Aviva Mcpherron as President of Global Operations and Quality | CI |
06-11 | Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.00% | 477M | |
-4.24% | 185B | |
-1.45% | 105B | |
-2.28% | 68.9B | |
+16.01% | 46.41B | |
-6.03% | 46.16B | |
+5.36% | 40.75B | |
+20.44% | 31.11B | |
+11.60% | 24.26B | |
-6.25% | 23.94B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Provides Net Sales Guidance for the Year Ended December 31, 2022